Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK2 | P53671 | 4/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | DGKZ | Q13574 | 1/20 | 0.37 |
| ▸ | SLC9A1 | P19634 | 5/20 | 0.36 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21787342 | 0.66 | OPRM1 (0.51) | OPRD1SLC6A9OPRM1OPRK1OPRL1 | |
| SCHEMBL13163119 | 0.66 | OPRM1 (0.51) | OPRD1SLC6A9OPRM1OPRK1OPRL1 | |
| SCHEMBL9792723 | 0.66 | OPRM1 (0.51) | OPRD1SLC6A9OPRM1OPRK1OPRL1 | |
| SCHEMBL4153281 | 0.64 | MEN1 (0.53) | OPRD1OPRM1OPRK1OPRL1 | |
| SCHEMBL4153276 | 0.64 | MEN1 (0.53) | OPRD1OPRM1OPRK1OPRL1 | |
| SCHEMBL13291353 | 0.63 | KDM4E (0.56) | OPRD1SLC6A9OPRM1OPRK1OPRL1 | |
| SCHEMBL14257980 | 0.63 | KDM4E (0.56) | OPRD1SLC6A9OPRM1OPRK1OPRL1 | |
| SCHEMBL4143908 | 0.62 | SLC6A9 (0.58) | OPRD1SLC6A9 | |
| SCHEMBL4143907 | 0.62 | SLC6A9 (0.58) | OPRD1SLC6A9 | |
| SCHEMBL4144761 | 0.62 | SLC6A9 (0.58) | OPRD1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5514800-A | CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA | SYNTEX PHARMACEUTICALS, LTD. (GB) | 1996-05-07 | — | — | US | disclosed |